Molecular testing for viral specimens
Ended Awarded Last action
- Contract number
- 36C24424F0411
- Awardee
-
Roche Diagnostics Corporation UEI JDMDFEZBYH36
- Awarding agency
-
Veterans Integrated Service Network 4
Veterans Health Administration, Department of Veterans Affairs
- Obligated
- $272,509
Award facts
- Contract value 100% obligated
- $272,508.99 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Contracting staff
- NAICS code
- 334516 Analytical Laboratory Instrument Manufacturing
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Philadelphia, PA 19104, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Supplemental Agreement for work within scope | -$46,838 | |
| Funding Only Action | -$159,245 | |
| Exercise an Option | $159,531 | |
| Exercise an Option | $159,531 | |
| Original award | $159,531 |
About this award
Roche Diagnostics Corporation was awarded a $272,508.99 firm fixed-price delivery order by Veterans Integrated Service Network 4 (VISN 4) to provide molecular testing for viral specimens, with performance in Philadelphia, PA and a completion date of September 9, 2024. This award, issued on June 10, 2024, represents a child delivery order under the Critical Analyzers, Laboratory (FSS-66-III) General Services Administration Schedule contract and was made without set-aside designation, indicating open competition. The work supports the Department of Veterans Affairs' civilian healthcare mission by supplying diagnostic molecular testing capabilities to veteran patient populations served by VISN 4.
This delivery order aligns with Roche Diagnostics' established role as a primary supplier of advanced diagnostic solutions to federal healthcare agencies. The company maintains an extensive portfolio of active indefinite delivery contracts and blanket purchase agreements across the Department of Veterans Affairs, including a $1.55 million BPA with VISN 4 specifically for molecular diagnostics reagents and tests through September 2026, of which this award appears to be a component. Roche's molecular diagnostic offerings include COBAS and COBAS 6800 analyzers with associated reagents and supplies, positioning the company to fulfill infectious disease testing requirements critical to veterans' healthcare delivery.
Quick answers
Who was awarded contract 36C24424F0411?
36C24424F0411 was awarded to Roche Diagnostics Corporation by Veterans Integrated Service Network 4 (Veterans Health Administration) on June 10, 2024.
How much is contract 36C24424F0411 worth?
The government has obligated $272,509 on 36C24424F0411. Its current value, with exercised options, is $272,509.
Is contract 36C24424F0411 an order under another contract?
Yes. 36C24424F0411 is a delivery order under V797D70105, a federal supply schedule, on Critical Analyzers, Laboratory (FSS-66-III).
Was contract 36C24424F0411 competed?
The extent of competition for 36C24424F0411 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award